Welcome to the Oncomine Blog

2021 European Association for Haematopathology Virtual Meeting Highlights

12/27/2021

2021 EAHP Symposium Overview

As part of the 20th Meeting of the European Association for Haematopathology virtual event, Thermo Fisher Scientific hosted an educational symposium focused on the uses of next-generation sequencing (NGS) in lymphoid..

NGS Enables Precision Oncology in Community-Based ...

Next-generation sequencing (NGS) technology has changed cancer treatment by enabling pathologists ...

How Diagnostics can Revolutionize Patient Care: ...

Precision medicine is a holistic approach to healthcare that combines knowledge of an individuals’ ...

University of Munich Evaluates the Oncomine ...

Our OncomineWorld event in 2021 brought thousands of professionals together from around the world ...

Case Study: High-Quality, Cost-Effective Genomic ...

In a recent case study interview, pathologist Federico Jauk, head of the Sequencing Laboratory at ...

Q&A: An Inside Look at Immune Repertoire Assay ...

Dr. Geoffrey Lowman Senior Staff Scientist, Molecular Biology, Clinical Sequencing Division Thermo ...

UAB Study Evaluates the Oncomine Myeloid Research ...

Performance of the Oncomine Myeloid Research Assay GX Craig Mackinnon, MD, PhD, Director of Genomic ...

Let’s Do It Ourselves - A global expert consensus ...

Over the last decade, precision oncology therapies dependent on biomarker-based diagnostics have ...

A Comprehensive Answer for Cancer: Is ...

What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of ...

Biomarker Tests for Precision Oncology: DIY or ...

Cancer patient management of is increasingly driven by biomarker assays – but how should we manage ...


Stay Up-To-Date

Subscribe and get the latest Oncomine content.

Subscribe